The Latest in Lymphoma & Plasma Cell Disorders

FDA grants priority review to sBLA for pembrolizumab

December 2, 2016

NCCN releases new guidelines for cancer patients

December 1, 2016

NICE recommends taking ibrutinib off CDF

November 30, 2016

Tazemetostat receives fast track designation for DLBCL

November 29, 2016

EC approves nivolumab for relapsed/refractory cHL

November 23, 2016

Novel CLL drugs could greatly increase costs

November 22, 2016

Large-scale tumor profiling deemed feasible, but challenges remain

November 20, 2016

How EBV drives lymphomagenesis

November 14, 2016

Drug dubbed ‘breakthrough’ for CTCL subtypes

November 12, 2016

NCCN issues challenge to ‘bag’ vincristine

November 11, 2016

CHMP recommends expanding use of drug in CLL

November 11, 2016

Tool provides info for cancer patients, survivors

November 10, 2016

Blood test can predict outcomes in DLBCL, team says

November 10, 2016

Drug elicits responses in heavily pretreated cHL

November 8, 2016

Combine flow and HTS for sensitive MRD detection in CLL, speaker says

November 4, 2016